Khaitan, JSA, TT&A Act On Viatris’ Divestment From Biocon Biotechnology & Pharma July 20, 2026 Capital Markets – Equity
SAM Advised On Biocon Biologics Merger; Khaitan, Cravath Act On Viatris’ Stake Sale In Biologics Biopharamaceuticals December 9, 2025 Mergers & Acquisitions
